Cytokinetics · 13 hours ago
Intern – Clinical Operations
San Francisco Bay Area
Internship
Onsite
Intern
$22/hr - $25/hrCytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology. They are seeking a highly motivated Intern to join their Clinical Operations group, supporting clinical trial operations and gaining hands-on experience in clinical research.
BiopharmaBiotechnologyHealth Care
Responsibilities
Support day-to-day clinical trial activities for the CY 1033 COMET study under guidance of study team members
Assist with preparation, review, and maintenance of study documentation (e.g., trial master file, study trackers, meeting minutes)
Help coordinate study-related activities, including site communications, study meetings, and follow-ups
Support data collection, entry, and quality checks in clinical trial systems
Assist with tracking study milestones, timelines, and deliverables
Support compliance with study protocols, GCP guidelines, and regulatory requirements
Participate in study team meetings and contribute to action item follow-up
Provide administrative and operational support to ensure smooth study execution
Assist with audit or inspection readiness activities as needed
Provide cross-study support for other clinical trials when required
Qualification
Required
Currently enrolled at an accredited college/university as a rising senior or higher
Effective oral and written communication skills. Able to communicate effectively with members of other departments and with study-site personnel (physicians, study coordinators, nurses, etc.) as needed
Ability to troubleshoot problems with team members
Proficiency with computer applications such as Word, Excel, and PowerPoint and able to learn other applications with appropriate training
Significant attention to detail, time management, and organizational skills
Company
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Founded in 1998
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.41BKey Investors
Royalty PharmaDeerfieldVulcan
2025-09-16Post Ipo Debt· $650M
2024-05-22Post Ipo Equity· $550M
2024-05-22Post Ipo Debt· $50M
Leadership Team
Robert Blum
President & CEO
Sung Lee
EVP & CFO
Recent News
GlobeNewswire
2026-01-13
Company data provided by crunchbase